Nutrition & DietNew Diabetes Pill Burns Fat by Activating Muscle Metabolism Without Ozempic Side Effects
Researchers at Karolinska Institutet and Stockholm University have developed an experimental pill for type 2 diabetes and obesity that works by activating metabolism in skeletal muscle rather than suppressing appetite. Unlike GLP-1 drugs such as Ozempic, this oral treatment appears to improve blood sugar, increase fat burning, and preserve muscle mass. A Phase I trial with 73 participants showed the drug was safe and well tolerated. Because muscle mass is directly linked to life expectancy and metabolic health, this approach could be especially valuable for aging adults. The drug may also complement existing GLP-1 therapies. A larger Phase II trial is now planned by the developing company, Atrogi AB.
